CN103877576A - Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 - Google Patents
Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 Download PDFInfo
- Publication number
- CN103877576A CN103877576A CN201410143793.2A CN201410143793A CN103877576A CN 103877576 A CN103877576 A CN 103877576A CN 201410143793 A CN201410143793 A CN 201410143793A CN 103877576 A CN103877576 A CN 103877576A
- Authority
- CN
- China
- Prior art keywords
- card3
- mice
- gene
- heart disease
- coronary atherosclerotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410143793.2A CN103877576B (zh) | 2014-04-10 | 2014-04-10 | Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410143793.2A CN103877576B (zh) | 2014-04-10 | 2014-04-10 | Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103877576A true CN103877576A (zh) | 2014-06-25 |
CN103877576B CN103877576B (zh) | 2017-01-11 |
Family
ID=50946910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410143793.2A Active CN103877576B (zh) | 2014-04-10 | 2014-04-10 | Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103877576B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107362372A (zh) * | 2017-09-07 | 2017-11-21 | 侯冬雪 | 使用crispr技术在冠状动脉粥样硬化性心脏病中的应用 |
CN107519492A (zh) * | 2017-09-06 | 2017-12-29 | 侯冬雪 | 使用CRISPR技术敲除miR‑3187‑3p在冠状动脉粥样硬化性心脏病中的应用 |
CN108913691A (zh) * | 2018-07-16 | 2018-11-30 | 洛阳轩智生物科技有限公司 | 表皮干细胞中采用CRISPR-Cas系统进行Card3基因敲除 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030035789A1 (en) * | 1999-12-16 | 2003-02-20 | Haval Shirwan | Compositions and methods for caspase-induced apoptosis |
CN102764292A (zh) * | 2012-07-31 | 2012-11-07 | 广州中医药大学 | 一种抑制心肌细胞凋亡的药物 |
CN103520162A (zh) * | 2013-10-15 | 2014-01-22 | 中国科学院上海药物研究所 | 达拉菲尼抑制程序性坏死和保护肝脏的应用 |
-
2014
- 2014-04-10 CN CN201410143793.2A patent/CN103877576B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030035789A1 (en) * | 1999-12-16 | 2003-02-20 | Haval Shirwan | Compositions and methods for caspase-induced apoptosis |
CN102764292A (zh) * | 2012-07-31 | 2012-11-07 | 广州中医药大学 | 一种抑制心肌细胞凋亡的药物 |
CN103520162A (zh) * | 2013-10-15 | 2014-01-22 | 中国科学院上海药物研究所 | 达拉菲尼抑制程序性坏死和保护肝脏的应用 |
Non-Patent Citations (2)
Title |
---|
KOTARO NAITO ET AL: "Nod1/RIP2 Signaling Regulates Cardiac Hypertrophic Response After Pressure Overload State", 《SCIENTIFIC SESSIONS AND RESUSCITATION SCIENCE SYMPOSIUM OF THE AMERICAN-HEART-ASSOCIATION》, vol. 128, no. 22, 26 November 2013 (2013-11-26) * |
张金亮: "新型非肽类小分子Caspase-3抑制剂的设计、合成、活性检测与分子对接研究", 《中国博士学位论文全文数据库 医药卫生科技辑》, no. 07, 15 July 2010 (2010-07-15) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107519492A (zh) * | 2017-09-06 | 2017-12-29 | 侯冬雪 | 使用CRISPR技术敲除miR‑3187‑3p在冠状动脉粥样硬化性心脏病中的应用 |
CN107362372A (zh) * | 2017-09-07 | 2017-11-21 | 侯冬雪 | 使用crispr技术在冠状动脉粥样硬化性心脏病中的应用 |
CN108913691A (zh) * | 2018-07-16 | 2018-11-30 | 洛阳轩智生物科技有限公司 | 表皮干细胞中采用CRISPR-Cas系统进行Card3基因敲除 |
CN108913691B (zh) * | 2018-07-16 | 2020-09-01 | 山东华御生物科技有限公司 | 表皮干细胞中采用CRISPR-Cas系统进行Card3基因敲除 |
Also Published As
Publication number | Publication date |
---|---|
CN103877576B (zh) | 2017-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103877576B (zh) | Caspase激活及募集结合域3(Card3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 | |
CN104107429B (zh) | Sh2b衔接蛋白3(sh2b3)在治疗心肌肥厚中的功能及应用 | |
CN103898189B (zh) | 信号调节蛋白α(SHSP-1)基因在心肌梗死中的应用 | |
CN103751804B (zh) | 干扰素调节因子4(irf4)基因在冠状动脉粥样硬化性心脏病中的应用 | |
CN105079785B (zh) | 三结构域蛋白32(trim32)在治疗心肌肥厚中的功能及应用 | |
CN103898190B (zh) | Toll作用蛋白(Tollip)基因在冠状动脉粥样硬化性心脏病中的应用 | |
CN103893763B (zh) | Vinexin-β基因在心肌梗死中的应用 | |
CN104117058B (zh) | 激活素受体样激酶7(alk7)在治疗心肌肥厚中的功能及应用 | |
CN105251020A (zh) | 泛素特异性蛋白酶4(usp4)在治疗心肌肥厚中的功能及应用 | |
CN103893781B (zh) | Dickkopf-3(DKK3)基因在冠状动脉粥样硬化性心脏病中的功能和应用 | |
CN103893743B (zh) | 生长分化因子1(gdf1)基因在冠状动脉粥样硬化性心脏病中的功能和应用 | |
CN105181976B (zh) | 三结构域蛋白8(trim8)抑制剂在抑制心肌肥厚中的功能及应用 | |
CN104107430B (zh) | IκB激酶ε抑制剂(SIKE)在治疗心肌肥厚中的功能及应用 | |
CN104141012A (zh) | Sh2b衔接蛋白1(sh2b1)在治疗心肌肥厚中的功能及应用 | |
CN105194673A (zh) | 生长抑制特异性蛋白6(gas6)在治疗心肌肥厚中的功能及应用 | |
CN105106942B (zh) | 双特异性磷酸酶14(dusp14)在治疗心肌肥厚中的功能及应用 | |
CN105194652B (zh) | A20结合的核因子抑制蛋白3(abin3)在治疗心肌肥厚中的功能及应用 | |
CN104174011B (zh) | 离心力和剪切力应答蛋白1(recs1)在治疗心肌肥厚中的功能及应用 | |
CN103751783B (zh) | Irf1在主动脉弓缩窄疾病中的功能及其抑制剂的应用 | |
CN105194653A (zh) | 锌指蛋白307(znf307)在治疗心肌肥厚中的应用 | |
CN103784972A (zh) | 干扰素调节因子9(irf9)及其抑制剂在冠状动脉粥样硬化性心脏病中的应用 | |
CN105194654B (zh) | 线粒体内膜转运蛋白50(tim50)在治疗心肌肥厚中的应用 | |
CN105181975B (zh) | 核定位蛋白1(Nulp1)在治疗心肌肥厚中的功能及应用 | |
CN105251021B (zh) | 线粒体相关核糖体gtp酶1(mtg1)在治疗心肌肥厚中的功能及应用 | |
CN104107418A (zh) | Carabin在治疗心肌肥厚中的功能及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191125 Address after: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee after: Wuhan Dafeng Biotechnology Co., Ltd Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Patentee before: WuHan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191218 Address after: 430014 3119, floor 3, building 9, Guanggu science and technology port, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan linyijia Gene Technology Co., Ltd Address before: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee before: Wuhan Dafeng Biotechnology Co., Ltd |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430076 room 002, 16 / F, building D2, phase III, software new town, No. 8, Huacheng Avenue, Wuhan East Lake New Technology Development Zone, Wuhan, Hubei Province Patentee after: Wuhan Huikang Gene Technology Co.,Ltd. Address before: Room 3119, 3 / F, building 9, Guanggu science and technology harbor, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430014 Patentee before: Wuhan linyijia Gene Technology Co.,Ltd. |